Table: Kyorin Holdings -2021/22 group results

Kyorin Pharmaceutical

11/05/2022 07:00

May 11 (Reuters)- 
          Kyorin Holdings Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR      
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales          105.53          102.90         112.00         49.60    
                               (-6.4 pct)     (+6.1 pct)    (+1.0 pct)  
  Operating        5.01            5.79           5.50        700 mln   
                               (-22.9 pct)    (+9.8 pct)                
  Recurring        5.57            6.45           6.00          1.00    
                               (-21.1 pct)    (+7.7 pct)   (+249.8 pct) 
  Net
  Net              3.93            6.13           4.50        700 mln   
                               (-0.3 pct)     (+14.4 pct)  (+475.2 pct) 
  EPS           68.62 yen      106.99 yen      78.53 yen     12.22 yen  
  Ann Div       52.00 yen       75.00 yen      52.00 yen                
  -Q2 Div       20.00 yen       30.00 yen      20.00 yen                
  -Q4 Div       32.00 yen       45.00 yen      32.00 yen                
  
  NOTE - Kyorin Holdings Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T